Stock Earnings
EyePoint Pharmaceuticals Inc [EYPT] Shares Fall Approximately -3.19% Over the Year
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. EyePoint Pharmaceuticals
Menu
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. EyePoint Pharmaceuticals
EyePoint Pharmaceuticals Inc’s filing revealed that its Director Zaderej Karen L. acquired Company’s shares for reported $29950.0 on May 19
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
EyePoint Pharmaceuticals Inc’s filing revealed that its Director Zaderej Karen L. acquired Company’s shares for reported $27350.0 on May 15
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
EyePoint Pharmaceuticals Inc’s recent filing unveils that its Director ANTHONY P. ADAMIS acquired Company’s shares for reported $0.67 million on